Nektar Therapeutics Increase (Decrease) in Other Operating Liabilities
Nektar Therapeutics (NKTR) reported Increase (Decrease) in Other Operating Liabilities of -$233.00 thousand for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2020-05-08
- Nektar Therapeutics increase (decrease) in other operating liabilities for the quarter ending 2020-03-31 was -$233.00K, a 242.07% decline year-over-year.
- Nektar Therapeutics increase (decrease) in other operating liabilities for the quarter ending 2019-12-31 was -$11.40M.
- Nektar Therapeutics increase (decrease) in other operating liabilities for the quarter ending 2019-09-30 was $3.23M, a 8875.00% increase year-over-year.
- Nektar Therapeutics increase (decrease) in other operating liabilities for the quarter ending 2019-06-30 was $8.54M, a 88.75% increase year-over-year.
- Nektar Therapeutics increase (decrease) in other operating liabilities for fiscal 2019 was $533.00K, a 84.96% decline from fiscal 2018.
- Nektar Therapeutics increase (decrease) in other operating liabilities for fiscal 2018 was $3.54M.
- Nektar Therapeutics increase (decrease) in other operating liabilities for fiscal 2017 was -$14.93M, a 273.14% decline from fiscal 2016.
- Nektar Therapeutics increase (decrease) in other operating liabilities for fiscal 2016 was $8.62M, a 184.37% increase from fiscal 2015.
| Period end | Increase (Decrease) in Other Operating Liabilities 3 month | Increase (Decrease) in Other Operating Liabilities 3 month as first filed | Increase (Decrease) in Other Operating Liabilities 6 month | Increase (Decrease) in Other Operating Liabilities 9 month | Increase (Decrease) in Other Operating Liabilities 9 month as first filed | Increase (Decrease) in Other Operating Liabilities 12 month | Increase (Decrease) in Other Operating Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2020-03-31 | -$233.00K 10-Q · filed 2020-05-08 | -$11.63M derived: sum of 2 quarters · filed 2020-05-08 | -$8.40M derived: sum of 3 quarters · filed 2020-05-08 | $136.00K derived: sum of 4 quarters · filed 2020-05-08 | |||
| 2019-12-31 | -$11.40M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | -$8.17M derived: sum of 2 quarters · filed 2020-02-28 | $369.00K derived: sum of 3 quarters · filed 2020-02-28 | $533.00K 10-K · filed 2020-02-28 | |||
| 2019-09-30 | $3.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $11.77M derived: sum of 2 quarters · filed 2019-11-07 | $11.93M 10-Q · filed 2019-11-07 | $10.37M derived: sum of 4 quarters · filed 2020-05-08 | |||
| 2019-06-30 | $8.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $8.70M 10-Q · filed 2019-08-09 | $7.14M derived: sum of 3 quarters · filed 2020-05-08 | $7.18M derived: sum of 4 quarters · filed 2020-05-08 | |||
| 2019-03-31 | $164.00K 10-Q · filed 2020-05-08 | $1.33M 10-Q · filed 2019-05-09 | -$1.40M derived: sum of 2 quarters · filed 2020-05-08 | -$1.36M derived: sum of 3 quarters · filed 2020-05-08 | $3.16M derived: sum of 4 quarters · filed 2020-05-08 | ||
| 2018-12-31 | -$1.56M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | -$1.52M derived: sum of 2 quarters · filed 2020-02-28 | $3.00M derived: sum of 3 quarters · filed 2020-02-28 | $3.54M 10-K · filed 2020-02-28 | |||
| 2018-09-30 | $36.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $4.56M derived: sum of 2 quarters · filed 2019-11-07 | $5.10M 10-Q · filed 2019-11-07 | -$10.87M derived: sum of 4 quarters · filed 2020-02-28 | |||
| 2018-06-30 | $4.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $5.07M 10-Q · filed 2019-08-09 | -$10.91M derived: sum of 3 quarters · filed 2020-02-28 | -$10.86M derived: sum of 4 quarters · filed 2020-02-28 | |||
| 2018-03-31 | $545.00K 10-Q · filed 2019-05-09 | -$15.43M derived: sum of 2 quarters · filed 2020-02-28 | -$15.38M derived: sum of 3 quarters · filed 2020-02-28 | -$11.87M derived: sum of 4 quarters · filed 2020-02-28 | |||
| 2017-12-31 | -$15.97M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | -$15.93M derived: sum of 2 quarters · filed 2020-02-28 | -$12.42M derived: sum of 3 quarters · filed 2020-02-28 | -$14.93M 10-K · filed 2020-02-28 | -$2.43M 10-K · filed 2018-03-01 | ||
| 2017-09-30 | $46.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $3.56M derived: sum of 2 quarters · filed 2018-11-08 | $1.05M 10-Q · filed 2018-11-08 | $15.46M derived: sum of 4 quarters · filed 2019-03-01 | |||
| 2017-06-30 | $3.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $1.00M 10-Q · filed 2018-08-09 | $15.41M derived: sum of 3 quarters · filed 2019-03-01 | $10.35M derived: sum of 4 quarters · filed 2019-03-01 | |||
| 2017-03-31 | -$2.51M 10-Q · filed 2018-05-10 | $11.91M derived: sum of 2 quarters · filed 2019-03-01 | $6.84M derived: sum of 3 quarters · filed 2019-03-01 | $4.38M derived: sum of 4 quarters · filed 2019-03-01 | |||
| 2016-12-31 | $14.41M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $9.35M derived: sum of 2 quarters · filed 2019-03-01 | $6.89M derived: sum of 3 quarters · filed 2019-03-01 | $8.62M 10-K · filed 2019-03-01 | -$3.88M 10-K · filed 2017-03-01 | ||
| 2016-09-30 | -$5.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | -$7.53M derived: sum of 2 quarters · filed 2017-11-08 | -$5.79M 10-Q · filed 2017-11-08 | -$6.62M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2016-06-30 | -$2.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$725.00K 10-Q · filed 2017-08-09 | -$1.55M derived: sum of 3 quarters · filed 2018-03-01 | -$9.46M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2016-03-31 | $1.74M 10-Q · filed 2017-05-10 | $914.00K derived: sum of 2 quarters · filed 2018-03-01 | -$7.00M derived: sum of 3 quarters · filed 2018-03-01 | -$5.51M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2015-12-31 | -$822.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | -$8.74M derived: sum of 2 quarters · filed 2018-03-01 | -$7.25M derived: sum of 3 quarters · filed 2018-03-01 | $3.03M 10-K · filed 2018-03-01 | |||
| 2015-09-30 | -$7.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | -$6.42M derived: sum of 2 quarters · filed 2016-11-04 | $3.85M 10-Q · filed 2016-11-04 | -$2.58M derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2015-06-30 | $1.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $11.77M 10-Q · filed 2016-08-04 | $5.34M derived: sum of 3 quarters · filed 2017-03-01 | $4.53M derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2015-03-31 | $10.28M 10-Q · filed 2016-05-04 | $3.84M derived: sum of 2 quarters · filed 2017-03-01 | $3.04M derived: sum of 3 quarters · filed 2017-03-01 | -$2.33M derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2014-12-31 | -$6.43M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | -$7.24M derived: sum of 2 quarters · filed 2017-03-01 | -$12.61M derived: sum of 3 quarters · filed 2017-03-01 | -$13.80M 10-K · filed 2017-03-01 | |||
| 2014-09-30 | -$809.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | -$6.17M derived: sum of 2 quarters · filed 2015-11-06 | -$7.37M 10-Q · filed 2015-11-06 | $6.62M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-06-30 | -$5.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | -$6.56M 10-Q · filed 2015-08-06 | $7.43M derived: sum of 3 quarters · filed 2016-02-29 | $3.83M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-03-31 | -$1.20M 10-Q · filed 2015-05-01 | $12.79M derived: sum of 2 quarters · filed 2016-02-29 | $9.19M derived: sum of 3 quarters · filed 2016-02-29 | $11.80M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2013-12-31 | $13.99M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $10.39M derived: sum of 2 quarters · filed 2016-02-29 | $12.99M derived: sum of 3 quarters · filed 2016-02-29 | $9.16M 10-K · filed 2016-02-29 | |||
| 2013-09-30 | -$3.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | -$995.00K derived: sum of 2 quarters · filed 2014-11-07 | -$4.83M 10-Q · filed 2014-11-07 | -$1.33M derived: sum of 4 quarters · filed 2015-02-26 | |||
| 2013-06-30 | $2.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-01 | -$1.22M 10-Q · filed 2014-08-01 | $2.27M derived: sum of 3 quarters · filed 2015-02-26 | $2.32M derived: sum of 4 quarters · filed 2015-02-26 | |||
| 2013-03-31 | -$3.83M 10-Q · filed 2014-05-08 | -$336.00K derived: sum of 2 quarters · filed 2015-02-26 | -$286.00K derived: sum of 3 quarters · filed 2015-02-26 | -$1.11M derived: sum of 4 quarters · filed 2015-02-26 | |||
| 2012-12-31 | $3.49M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | $3.54M derived: sum of 2 quarters · filed 2015-02-26 | $2.72M derived: sum of 3 quarters · filed 2015-02-26 | $3.27M 10-K · filed 2015-02-26 | |||
| 2012-09-30 | $50.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | -$775.00K derived: sum of 2 quarters · filed 2013-11-07 | -$219.00K 10-Q · filed 2013-11-07 | $1.31M 10-Q · filed 2012-11-09 | $1.52M derived: sum of 4 quarters · filed 2014-02-27 | ||
| 2012-06-30 | -$825.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | -$269.00K 10-Q · filed 2013-08-09 | $1.47M derived: sum of 3 quarters · filed 2014-02-27 | -$554.00K derived: sum of 4 quarters · filed 2014-02-27 | |||
| 2012-03-31 | $556.00K 10-Q · filed 2013-05-09 | -$1.19M 10-Q · filed 2012-05-04 | $2.29M derived: sum of 2 quarters · filed 2014-02-27 | $271.00K derived: sum of 3 quarters · filed 2014-02-27 | $1.16M derived: sum of 4 quarters · filed 2014-02-27 | ||
| 2011-12-31 | $1.74M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | -$285.00K derived: sum of 2 quarters · filed 2014-02-27 | $601.00K derived: sum of 3 quarters · filed 2014-02-27 | -$943.00K 10-K · filed 2014-02-27 | |||
| 2011-09-30 | -$2.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | -$1.14M derived: sum of 2 quarters · filed 2012-11-09 | -$2.68M 10-Q · filed 2012-11-09 | -$879.00K derived: sum of 4 quarters · filed 2013-03-01 | |||
| 2011-06-30 | $886.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | -$658.00K 10-Q · filed 2012-08-09 | $1.14M derived: sum of 3 quarters · filed 2013-03-01 | -$176.00K derived: sum of 4 quarters · filed 2013-03-01 | |||
| 2011-03-31 | -$1.54M 10-Q · filed 2012-05-04 | $258.00K derived: sum of 2 quarters · filed 2013-03-01 | -$1.06M derived: sum of 3 quarters · filed 2013-03-01 | -$489.00K derived: sum of 4 quarters · filed 2013-03-01 | |||
| 2010-12-31 | $1.80M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | $482.00K derived: sum of 2 quarters · filed 2013-03-01 | $1.05M derived: sum of 3 quarters · filed 2013-03-01 | -$247.00K 10-K · filed 2013-03-01 | |||
| 2010-09-30 | -$1.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | -$747.00K derived: sum of 2 quarters · filed 2011-11-04 | -$2.05M 10-Q · filed 2011-11-04 | ||||
| 2010-06-30 | $573.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-05 | -$729.00K 10-Q · filed 2011-08-05 | |||||
| 2010-03-31 | -$1.30M 10-Q · filed 2011-04-29 | ||||||
| 2009-12-31 | -$559.00K 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |